Open access
Sep 2026
Lipoprotein(a) in acute myocardial infarction - insights from the randomised ASSAIL-MI trial.
BACKGROUND AND AIMS Elevated circulating levels of lipoprotein(a) [Lp(a)] increase the risk of cardiovascular events. Plasma concentrations of biomarkers and lipoproteins may change substantially in the aftermath of myocardial infarction and may fluctuate with inflammation and lipid-lowering treatment. We aimed to asse...
K. Broch, Arne K. Andreassen, A. K. Anstensrud et al.
· Atherosclerosis · 0 citations